scispace - formally typeset
Open AccessJournal ArticleDOI

Clinical Grade Manufacturing of Human Alloantigen-Reactive Regulatory T Cells for Use in Transplantation

TLDR
The alloantigen‐expanded Tregs had a diverse TCR repertoire and were more potent than PolyTregs in vitro and more effective at controlling allograft injuries in vivo in a humanized mouse model.
About
This article is published in American Journal of Transplantation.The article was published on 2013-11-01 and is currently open access. It has received 249 citations till now. The article focuses on the topics: Regulatory T cell & Transplantation.

read more

Citations
More filters
Journal ArticleDOI

Type 1 diabetes immunotherapy using polyclonal regulatory T cells.

TL;DR: A phase 1 trial of adoptive Treg immunotherapy to repair or replace Tregs in type 1 diabetics was reported, and the therapy was safe, supporting efficacy testing in further trials and support the development of a phase 2 trial to test efficacy of the Treg therapy.
Journal ArticleDOI

Past, Present, and Future of Regulatory T Cell Therapy in Transplantation and Autoimmunity.

TL;DR: The understanding of Tregs is described, primarily on their ontogenesis, mechanisms of action and methods used in the clinic for isolation and expansion, which will describe the ongoing studies and the results from the first clinical trials with T Regs in the setting of solid organ transplantation and autoimmune disorders.
Journal ArticleDOI

Alloantigen-specific regulatory T cells generated with a chimeric antigen receptor

TL;DR: The results demonstrate that use of CAR technology to generate potent, functional, and stable alloantigen-specific human Tregs markedly enhances their therapeutic potential in transplantation and sets the stage for using this approach for making antigen-specific T Regs for therapy of multiple diseases.
Journal ArticleDOI

Treg cell-based therapies: challenges and perspectives.

TL;DR: The biology of Treg cells is discussed and new efforts in Treg cell engineering to enhance specificity, stability, functional activity and delivery are described to encourage the clinical use of adoptive TReg cell therapy for non-immune diseases, such as neurological disorders and tissue repair.
Journal ArticleDOI

Advances in islet encapsulation technologies

TL;DR: Although encapsulation technology has met several challenges, the convergence of expertise in materials, nanotechnology, stem cell biology and immunology is allowing the goal of encapsulated islet cell therapy for humans to be closer.
References
More filters
Journal ArticleDOI

Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self.

TL;DR: Naturally arising CD25+CD4+ regulatory T cells actively maintain immunological self-tolerance, and are a good target for designing ways to induce or abrogate immunological tolerance to self and non-self antigens.
Journal ArticleDOI

Regulatory T cells in transplantation tolerance.

TL;DR: The origin, allorecognition properties and molecular basis for the suppressive activity of CD4+CD25+ TReg cells, as well as their relationship to other populations of regulatory cells that exist after transplantation, remain a matter of debate.
Journal ArticleDOI

Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: safety profile and detection kinetics.

TL;DR: There was a reduced incidence of grade II-IV aGVHD with no deleterious effect on risks of infection, relapse, or early mortality and the results set the stage for a definitive study of UCB Treg to determine its potency in preventing allogeneic aGV HD.
Book ChapterDOI

Regulatory T cells in transplantation tolerance.

TL;DR: The authors' ability to harness tolerance mechanisms will have a major impact in organ transplantation if it becomes possible to minimize drug maintenance, or even wean off immunosuppressive drugs.
Related Papers (5)